ArticleInternational journal of clinical and experimental medicine2015
Temporal and spatial changes in VEGF, αA- and αB-crystallin expression in a mouse model of oxygen-induced retinopathy.
Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- Article
- Mesenchymal stem cell dysfunction in diabetes.Molecular biology reports · 2019Review
- Heat Shock Proteins Regulatory Role in Neurodevelopment.Frontiers in neuroscience · 2018Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveRetinal neovascularization is an iconic change in retinopathies. Vascular Endothelial Growth Factor (VEGF) and α-crystallins have been identified to mediate the pathogenesis of retinopathy. However, the special and temporal changes in their expression associated with retinal neovascularization have not yet been determined. Therefore, we examined the expression and distribution of VEGF, αA- and αB-crystallins in the retina using a mouse model of oxygen-induced retinopathy (OIR).
methods90 C57/BL mice were randomly divided into the OIR and control groups. The OIR group at postnatal day 7 (P7) were kept at high oxidation state (75 ± 5%) for 5 days before returned to normal environment. Retinal tissue was cut into sections. Oxygen induced retinal neovascularization and vascular structural changes were evaluated using retinal fluorescein angiography. The number of endothelial cell nuclei breaking through the retinal internal limiting membrane was counted after H&E staining. The mRNA expression levels of VEGF, αA- and αB-crystallins in the mouse retina were determined using real-time RT-PCR. The distribution of αA- and αB-crystallins in the retina was detected by fluorescent immunohistochemistry staining.
resultsOxygen induction triggered new blood vessel formation in the retina and impaired the structure of the retinal vascular network. The number of endothelial cell nuclei breaking through the retinal internal limiting membrane was significantly increased in the OIR group compared to the control group at P13, P17 and P21 (P < 0.01), reaching the peak on P17. The expression levels of VEGF, αA- and αB-crystalllins were also significantly different between the OIR and control groups. VEGF expression was highest on P15, αA-crystallin expression was highest on P17, whereas αB-crystallin expression kept increasing during the time frame of our study. Both αA- and αB-crystallins were expressed in the ganglion cell layer and the inner nuclear cell layer. While αA- and αB-crystallins were only located on the cell membrane in the outer ganglion cell layer, they were observed both on the cell membrane and in the cytoplasm in the inner layer of cells.
conclusionUsing our mouse model of oxygen-induced retinopathy, we showed that the expression patterns of VEGF, αA- and αB-crystallins during retinal neovascularization in both spatially and temporally manners, providing significant insights into the molecular mechanisms of retinopathy and the associated neovascularization.
Indexed as
Identifiers
26064225PMC4443059W2409839851What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.